ACM
AMAG

Apex Capital Management’s AMAG Pharmaceuticals AMAG Stock Holding History

Apex Capital Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$6.91M Buy
295,414
+12,178
+4% +$289K 0.15% 135
2015
Q4 		$8.55M Sell
283,236
-6,771
-2% -$219K 0.19% 118
2015
Q3 		$11.5M Buy
290,007
+10,924
+4% +$678K 0.26% 92
2015
Q2 		$19.3M Buy
+279,083
New +$17.6M 0.41% 74

Other funds holding AMAG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIM
Stelliam Investment Management New York $404M AUM 5.1% 1-Year Est. Return

Apex Capital Management's AMAG Position: Q1 2016 in Review

Apex Capital Management increased its AMAG Pharmaceuticals (AMAG) stake by 4.3% in Q1 2016, buying an estimated $289K and bringing the position to 295,414 shares worth $6.91M. The position accounts for 0.15% of the portfolio, ranked #135.

Apex Capital Management first reported a position in AMAG in Q2 2015 and has held it in 4 quarters since. The position peaked at $19.3M in Q2 2015. 185 funds tracked by Wall St. Rank hold AMAG as of Q1 2016.

  • Apex Capital Management held 295,414 shares of AMAG Pharmaceuticals worth $6.91M as of Q1 2016.
  • Apex Capital Management bought 12,178 AMAG Pharmaceuticals shares in Q1 2016, an estimated $289K.
  • AMAG Pharmaceuticals made up 0.15% of Apex Capital Management's portfolio in Q1 2016, its #135 holding.
  • Apex Capital Management first reported a position in AMAG Pharmaceuticals in Q2 2015 and has held it in 4 quarters since.
  • Apex Capital Management's AMAG Pharmaceuticals position peaked at $19.3M in Q2 2015.
  • 185 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2016.

Based on Apex Capital Management's 13F filing for Q1 2016, filed 27 Apr 2016.